
Researchers have linked a specific protein, CCL28, to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent development of post-viral asthma in young children.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/EvhKcm3eawQ/150220133344.htm